Chang, Kwang-Yu <br/><br/>
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2011 
 - 7116-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-11-0796  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Evaluation, Preclinical<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Mice<br/>Mice, Nude<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinolines--therapeutic use<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays